EDIT – editas medicine, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

EDIT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/20

04:01 pm

edit

Editas Medicine Announces Chief Financial Officer Transition

Medium Report

Editas Medicine Announces Chief Financial Officer Transition

Report

3/13

07:16 am

edit

Here's Why Editas Medicine (NASDAQ:EDIT) Must Use Its Cash Wisely [Yahoo! Finance]

Medium Report

Here's Why Editas Medicine (NASDAQ:EDIT) Must Use Its Cash Wisely [Yahoo! Finance]

Report

3/5

07:06 pm

edit

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates [Yahoo! Finance]

Medium Report

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates [Yahoo! Finance]

Report

3/5

04:05 pm

edit

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

High Report

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

Report

2/24

10:05 am

edit

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March [Yahoo! Finance]

Medium Report

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March [Yahoo! Finance]

Report

2/24

09:00 am

edit

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March

Medium Report

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March

Report

1/14

09:58 am

edit

Editas Medicine Outlines 2025 Strategic Priorities and Milestones [Yahoo! Finance]

Low Report

Editas Medicine Outlines 2025 Strategic Priorities and Milestones [Yahoo! Finance]

Report

1/13

09:00 am

edit

Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities

Medium Report

Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities

Report

1/6

09:00 am

edit

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Medium Report

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.